Nonoperating Income (Expense) of Lomond Therapeutics Holdings, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lomond Therapeutics Holdings, Inc. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Lomond Therapeutics Holdings, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $68,249.
  • Lomond Therapeutics Holdings, Inc. annual Nonoperating Income (Expense) for 2024 was $800,000, a 300% increase from 2023.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Lomond Therapeutics Holdings, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $68,249 +$992,728 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q1 2025 $300,000 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q3 2024 $924,479 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3

Lomond Therapeutics Holdings, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $800,000 +$600,000 +300% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $200,000 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.